克服营养压力:因特林αvβ3驱动的代谢适应支持瘤启动
1School of Biosciences, University of Sheffield, Sheffield, United Kingdom.
Cancer research
|May 15, 2024
概括
肺癌细胞通过升高整合素β3的调节来生存营养压力,这增强了谷氨酸代谢和氧化酸化 (OXPHOS). 针对这种途径可以防止瘤生长和转移.
科学领域:
- 在瘤学瘤学.
- 癌症新陈代谢 癌症新陈代谢
- 细胞适应 细胞适应
背景情况:
- 营养压力在瘤中很常见,促进癌细胞存活和转移.
- 代谢重编程是癌症的一个关键标志,使得癌症能够适应压力条件.
- 集成蛋白β3是一种细胞外矩阵受体,在细胞存活和癌症进展中起作用.
研究的目的:
- 调查整合素β3在营养压力下肺癌细胞存活中的作用.
- 阐明整合素β3在营养饥饿期间促进生存的分子机制.
- 评估向肺癌中整合素β3信号通路的治疗潜力.
主要方法:
- 在营养饥饿的情况下,分析肺癌细胞中整合素β3表达的分析.
- 研究由整合素β3激活的信号通路,包括Src,AMPK和PGC1α.
- 在体内使用带有或没有β3淘汰或OXPHOS抑制的正位肺癌模型.
主要成果:
- 在营养饥饿期间,整体蛋白β3在肺癌细胞中被上调,独立于ECM结合,增强了生存率.
- 综合素β3激活Src/AMPK/PGC1α通路促进了谷氨胺代谢和氧化酸化 (OXPHOS).
- 在体内,OXPHOS抑制减少了瘤开始,而β3淘汰完全阻止了它.
结论:
- 集成蛋白β3在营养缺乏条件下使肺癌细胞存活和增殖起到关键作用.
- 已识别的Src/AMPK/PGC1α通路在整合素β3的下游,对于代谢适应和瘤启动至关重要.
- 针对αvβ3下游的信号通路提供了针对肺癌进展和转移的潜在治疗策略.
相关概念视频
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Intracellular Signaling Affects Focal Adhesions
2.7K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
2.7K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K


